Related content

Between-Arm Comparisons in Randomized Phase II Trials

By Jung Sin-Ho   George Stephen  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 456-468

Taylor & Francis Ltd

Access to resources Recommend Favorite

An update on bronchodilators in Phase I and II clinical trials

By Cazzola Mario   Rogliani Paola   Segreti Andrea   Matera Maria Gabriella  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1489-1501

Informa Healthcare

Access to resources Recommend Favorite

Selecting Promising Treatments in Randomized Phase II Cancer Trials with an Active Control

By Cheung Ying Kuen  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 494-508

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Two-Stage Randomized Multinomial Designs for Phase II Oncology Trials

By Sun Linda  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 485-493

Taylor & Francis Ltd

Access to resources Recommend Favorite

Estimation of Multiple Response Rates in Phase II Clinical Trials with Missing Observations

By Chang Myron  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 791-802

Taylor & Francis Ltd

Access to resources Recommend Favorite